• 1
    Fonseca Pacheco AG, Tuboi S, Faulhaber JC, et al. Significant increases in cardiovascular diseases and diabetes as causes of death in HIV-infected individuals in the HAART era in Brazil: a population-based analysis. Presented at: 4th IAS Conference on Pathogenesis, Treatment and Prevention; July 2225, 2007; Sydney, Australia. Abstract WEAB301.
  • 2
    Fact Sheet. HIV/AIDS. National Institutes of Health. Accessed November 19, 2007.
  • 3
    Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397406.
  • 4
    Friis-Moller N, Reiss P, Sabin CA, et al, for the DAD study group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:17231735.
  • 5
    El-Sadr WM, Lundgren JD, Neaton JD, et al. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:22832296.
  • 6
    Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and Dependent Areas, 2005. HIV/AIDS Surveillance Report 17. Revised edition, June 2007.
  • 7
    Centers for Disease Control and Prevention (CDC). Twenty-five years of HIV/AIDS—United States, 1981–2006. MMWR Morb Mortal Wkly Rep. 2006;55:585589.
  • 8
    Beaglehole R, Reddy S, Leeder SR. Poverty and human development: the global implications of cardiovascular disease. Circulation. 2007;116:18711873.